Close

News

Daiichi Sankyo to buy Ambit Biosciences for $410m

Japan-based Daiichi Sankyo has signed an agreement to acquire US-based Ambit Biosciences, for about $410m. As part of the deal, Daiichi will pay $15 per share in cash to Ambit through a tender offer,...

Cipla Medpro to market Teva’s pharmaceutical products in South Africa

Cipla Medpro subsidiary Medpro Pharmaceutica has entered into an agreement with Teva Pharmaceuticals. As part of the deal, Medpro will exclusively market Teva's pharmaceutical product portfolio in South Africa. Cipla Medpro CEO Paul Miller said:...

Nabriva’s lefamulin receives FDA fast-track status to treat CABP and ABSSSI

Austria-based Nabriva Therapeutics has received qualified infectious disease product (QIDP) and fast-track status designation from the US Food and Drug Administration for its lefamulin (BC 3781). The designation has been granted for lefamulin...

Pfizer introduces new medicines optimisation scratch card

US-based Pfizer has introduced a new scratch card in a bid to involve the public in medicines optimisation. The card has been designed to increase patient engagement with the pharmacy team and create opportunities to...

Johnson & Johnson to acquire Alios BioPharma for $1.75bn

US-based Johnson & Johnson has signed an agreement to acquire a privately held clinical stage biopharmaceutical company, Alios BioPharma, for $1.75bn in cash. Based in California, US, Alios develops therapies for the treatment of...

In US, FedEx faces drug trafficking charges

The courier firm FedEx faces drug-trafficking charges after being indicted by a federal grand jury in California, in a case that highlights the growth in illegal online pharmacies selling dubious medication to people without prescription. The...

AIDS can be brought under control by 2030: UNAIDS

AIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said the number of new HIV infections and deaths from Aids were both falling. At present,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »